3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
67
Lymphoma, Follicular
21
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Mantle-Cell
10
Lymphoma
10
Recurrence
7
Neoplasms, Plasma Cell
7
Lymphoma, B-Cell, Marginal Zone
7
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Smoldering Multiple Myeloma
4
Neoplasms
3
Neuroblastoma
2
Neoplasm, Residual
2
Myelodysplastic Syndromes
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Hematologic Diseases
2
Burkitt Lymphoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Interventions
Bevacizumab
56
Cetuximab
50
Fluorouracil
45
Leucovorin
39
Oxaliplatin
38
pembrolizumab
31
Specimen Handling
27
Irinotecan
25
Magnetic Resonance Spectroscopy
17
Biopsy
17
Nivolumab
15
Capecitabine
14
HMPL-013
13
Folfox protocol
13
Gemcitabine
12
Cisplatin
12
trifluridine tipiracil drug combination
11
Panitumumab
11
Carboplatin
11
Pemetrexed
9
IFL protocol
9
encorafenib
8
balstilimab
8
Standard of Care
8
Paclitaxel
8
Early Intervention, Educational
8
130-nm albumin-bound paclitaxel
8
fludarabine
7
atezolizumab
7
Educational Status
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Lenalidomide
×
90 days
×
Clear all
No trials found.